339 related articles for article (PubMed ID: 33837779)
1. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
[TBL] [Abstract][Full Text] [Related]
3. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
5. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A; Pal P; Basu S
Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
[TBL] [Abstract][Full Text] [Related]
6. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C
Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036
[TBL] [Abstract][Full Text] [Related]
8. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S; Yıldız K; Acarı C; Dundar HA; Kır M; Ünsal E
Turk J Pediatr; 2020; 62(1):1-9. PubMed ID: 32253860
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y; Li H; Luo D; Jiang J; Liu B; Li G
Int Immunopharmacol; 2023 Sep; 122():110600. PubMed ID: 37423157
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
[TBL] [Abstract][Full Text] [Related]
13. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[TBL] [Abstract][Full Text] [Related]
15. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
[TBL] [Abstract][Full Text] [Related]
16. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
17. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease - A Multicenter Retrospective Study.
Okuma Y; Suda K; Nakaoka H; Katsube Y; Mitani Y; Yoshikane Y; Ichida F; Matsushita T; Shichino H; Shiraishi I; Abe J; Hiroe M; Yoshida T; Imanaka-Yoshida K
Circ J; 2016 Oct; 80(11):2376-2381. PubMed ID: 27746411
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
Pediatr Rheumatol Online J; 2019 Nov; 17(1):78. PubMed ID: 31775782
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of sampling-time specific prognostic nutritional index cut-off values for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease.
Liu X; Shao S; Zhang N; Wu M; Liu L; Duan H; Liu Z; Zhou K; Hua Y; Wang C
Int Immunopharmacol; 2022 Sep; 110():108986. PubMed ID: 35764015
[TBL] [Abstract][Full Text] [Related]
20. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S; Zhang H; Zhang R; Tang M; Luo E; Yang Y; Gao Y; Yue S; Liang H; Cai J
J Pediatr (Rio J); 2023; 99(4):406-412. PubMed ID: 36977496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
